Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Natsuko Uekawa is active.

Publication


Featured researches published by Natsuko Uekawa.


FEBS Letters | 2005

Zizimin2: a novel, DOCK180-related Cdc42 guanine nucleotide exchange factor expressed predominantly in lymphocytes

Akihiko Nishikimi; Nahum Meller; Natsuko Uekawa; Ken-ichi Isobe; Martin A. Schwartz; Mitsuo Maruyama

A novel superfamily of guanine nucleotide exchange factors for Rho GTPases includes DOCK180 and zizimin1. The zizimin subfamily includes three genes of which only zizimin1 has been cloned. We report here the cloning of zizimin2, identified in a screen for genes enriched in germinal center B cells. Zizimin2 and zizimin1 have similar primary structures and both proteins bound and activated Cdc42 but not the Cdc42‐related proteins TC10 or TCL. Their tissue distributions are distinct, however, with zizimin2 expressed predominantly in lymphocytes and an opposite pattern for zizimin1. Zizimin3 was also analyzed and showed distinct GTPase specificity and tissue distribution.


Experimental Cell Research | 2010

Crucial role of vinexin for keratinocyte migration in vitro and epidermal wound healing in vivo.

Noriyuki Kioka; Takuya Ito; Hiroshi Yamashita; Natsuko Uekawa; Tsutomu Umemoto; Soh Motoyoshi; Hiroshi Imai; Kenzo Takahashi; Hideto Watanabe; Masayasu Yamada; Kazumitsu Ueda

In the process of tissue injury and repair, epithelial cells rapidly migrate and form epithelial sheets. Vinexin is a cytoplasmic molecule of the integrin-containing cell adhesion complex localized at focal contacts in vitro. Here, we investigated the roles of vinexin in keratinocyte migration in vitro and wound healing in vivo. Vinexin knockdown using siRNA delayed migration of both HaCaT human keratinocytes and A431 epidermoid carcinoma cells in scratch assay but did not affect cell proliferation. Induction of cell migration by scratching the confluent monolayer culture of these cells activated both EGFR and ERK, and their inhibitors AG1478 and U0126 substantially suppressed scratch-induced keratinocyte migration. Vinexin knockdown in these cells inhibited the scratch-induced activation of EGFR, but not that of ERK, suggesting that vinexin promotes cell migration via activation of EGFR. We further generated vinexin (-/-) mice and isolated their keratinocytes. They similarly showed slow migration in scratch assay. Furthermore, vinexin (-/-) mice exhibited a delay in cutaneous wound healing in both the back skin and tail without affecting the proliferation of keratinocytes. Together, these results strongly suggest a crucial role of vinexin in keratinocyte migration in vitro and cutaneous wound healing in vivo.


FEBS Letters | 2004

Involvement of IL-1 family proteins in p38 linked cellular senescence of mouse embryonic fibroblasts

Natsuko Uekawa; Akihiko Nishikimi; Ken-ichi Isobe; Yoichiro Iwakura; Mitsuo Maruyama

Senescence of mammalian cultured cells is essentially organized by a machinery of cell division and cellular stresses induced by various extracellular stimuli. Here, we show that in mouse embryonic fibroblasts (MEFs) culture in vitro, expression of an inflammatory cytokine, interleukin‐1β (IL‐1β) and its antagonist, IL‐1 receptor antagonist (IL‐1Ra) are induced by senescence. The kinetics of IL‐1β‐expression was similar to that of p38 activation during MEFs culture. We also found a distinguishable accelerated senescence in cell growth in IL‐1Ra deficient MEFs culture. Our results suggest that IL‐1β signaling pathway is involved in activation of p38 linked cellular senescence.


Journal of Cancer Research and Clinical Oncology | 2006

Cancer-associated loss of TARSH gene expression in human primary lung cancer

Kunihiko Terauchi; Junichi Shimada; Natsuko Uekawa; Takeshi Yaoi; Mitsuo Maruyama; Shinji Fushiki

Purpose: We have previously identified mouse Tarsh as one of the cellular senescence-related genes and showed the loss of expression of TARSH mRNA in four human lung cancer cell lines. TARSH is a presumptive signal transduction molecule interacting with NESH, which is implicated to have some roles in lung cancer metastasis. Methods: The amplification of complete ORF-encoding TARSH cDNA was done with reverse transcription-PCR. Northern blotting was carried out using TARSH cDNA probes. To clarify the relationship between TARSH and lung cancer, we quantified TARSH mRNA expression in 15 human lung cancer cell lines and 32 primary non-small cell lung cancers. Results: We first determined the complete ORF-encoding cDNA sequence which is expressed in the human lung. On the Northern hybridization analysis, TARSH was strongly expressed in the human lung. The expression of TARSH mRNA is remarkably downregulated in all the lung cancer cell lines examined. Furthermore, TARSH expression was significantly low in all of the tumor specimens when compared to the expression in corresponding non-neoplastic lung tissue specimens. Conclusion: The cancer-associated transcriptional inactivation of TARSH suggests that TARSH could be used as a biomarker for lung cancer development as well as a molecular adjunct for lung carcinogenesis in human.


Biochemical and Biophysical Research Communications | 2009

Implication of p53-dependent cellular senescence related gene, TARSH in tumor suppression

Takeshi Wakoh; Natsuko Uekawa; Kunihiko Terauchi; Masataka Sugimoto; Akihito Ishigami; Junichi Shimada; Mitsuo Maruyama

A novel target of NESH-SH3 (TARSH) was identified as a cellular senescence related gene in mouse embryonic fibroblasts (MEFs) replicative senescence, the expression of which has been suppressed in primary clinical lung cancer specimens. However, the molecular mechanism underlying the regulation of TARSH involved in pulmonary tumorigenesis remains unclear. Here we demonstrate that the reduction of TARSH gene expression by short hairpin RNA (shRNA) system robustly inhibited the MEFs proliferation with increase in senescence-associated beta-galactosidase (SA-beta-gal) activity. Using p53-/- MEFs, we further suggest that this growth arrest by loss of TARSH is evoked by p53-dependent p21(Cip1) accumulation. Moreover, we also reveal that TARSH reduction induces multicentrosome in MEFs, which is linked in chromosome instability and tumor development. These results suggest that TARSH plays an important role in proliferation of replicative senescence and may serve as a trigger of tumor development.


FEBS Letters | 2006

Death-associated protein 3 regulates cellular senescence through oxidative stress response

Yoko Murata; Takeshi Wakoh; Natsuko Uekawa; Masataka Sugimoto; Azusa Asai; Tadaaki Miyazaki; Mitsuo Maruyama

Death‐associated protein 3 (DAP3) has been originally identified as a positive mediator of apoptosis. It has been revealed recently that the predominant localization of DAP3 to mitochondria implies its functional involvement in mitochondrial metabolism in addition to apoptosis. However, little is known about the molecular basis of these physiological functions of DAP3. Here, we demonstrate that DAP3 is reduced in both replicative and premature senescence induced by oxidative stress, and the DAP3 reduction induced by oxidative stress is observed mostly in a mitochondrial fraction. Using DAP3‐specific short hairpin RNA (shRNA) in a clonogenic survival assay, we reveal that reduction of DAP3 induces resistance to oxidative stress and decreases intracellular reactive oxygen species (ROS) production. Furthermore, this strategy allows us to show that loss of DAP3 is involved in the avoidance of replicative senescence in mouse embryonic fibroblasts (MEFs). Thus, our study offers an insight into the potential regulatory function of mitochondrial DAP3 involved in cellular senescence.


Journal of Experimental Zoology | 2000

Involvement of glycolytic metabolism in developmental inhibition of rat two-cell embryos by phosphate.

Akihiko Nishikimi; Natsuko Uekawa; Masayasu Yamada

To elucidate the mechanism by which phosphate induces developmental inhibition of rat 2-cell embryos, we examined the mutual effects of glucose and other glycolytic and non-glycolytic sugars, the non-metabolizable glucose analogue, and glycolytic inhibitors on the inhibitory effect of phosphate. In the absence of glucose, 30-49% of embryos treated with 10-500 microM phosphate were able to develop to morula and blastocysts. On the other hand, in the presence of 5 mM glucose, 10 microM phosphate decreased the developmental rate of 2-cell embryos to the 4-cell stage and completely inhibited the development beyond the 4-cell stage. In contrast, glucose showed no influence on development in phosphate-free medium. Similarly to glucose, the other glycolytic sugars fructose (5 mM) and mannose (5 mM) enhanced the inhibitory effect of 10 microM phosphate but had no influence in the absence of phosphate. In contrast, the non-glycolytic sugar and non-metabolizable glucose analogue N-acetylglucosamine and 3-O-methylglucose (3-O-MGlc), respectively, did not enhance the effects of phosphate. 2-Deoxyglucose (2DGlc), another glucose analogue that is non-metabolizable but is converted by hexokinase to 2DGlc 6-phosphate, at concentrations as low as 0.1 mM completely inhibited cell cycle progression of 2-cell embryos cultured in glucose-free (Glc(-)) medium with 10 microM phosphate. In contrast, in the absence of phosphate, 2DGlc at the same concentration allowed 55% of 2-cell embryos to develop to morula and blastocyst stages. Addition of an inhibitor of enolase in glycolysis, sodium fluoride (NaF), at 1 mM to the Glc(-) medium also enhanced the inhibitory effects of 10 microM phosphate, whereas 1 mM NaF in the absence of phosphate showed no inhibitory effects on the development of 2-cell embryos to morula and blastocyst stages. From these results, disturbance of glycolysis is a critical reason for the developmental inhibition caused by phosphate in early rat embryos in culture.


Biochemical and Biophysical Research Communications | 2005

Expression of TARSH gene in MEFs senescence and its potential implication in human lung cancer

Natsuko Uekawa; Kunihiko Terauchi; Akihiko Nishikimi; Junichi Shimada; Mitsuo Maruyama


Life Sciences | 2006

A novel alternative splice variant of nicastrin and its implication in Alzheimer disease.

Noriaki Mitsuda; Hidehisa Yamagata; Wangtao Zhong; Mamoru Aoto; Hiroyasu Akatsu; Natsuko Uekawa; Kouzin Kamino; Keiko Taguchi; Takayuki Yamamoto; Mitsuo Maruyama; Kenji Kosaka; Masatoshi Takeda; Ikuko Kondo; Tetsuro Miki


Hybridoma | 2007

Generation and Characterization of Novel Monoclonal Antibodies Against Murine and Human TARSH Proteins

Natsuko Uekawa; Tomohisa Nishioka; Kunihiko Terauchi; Satoshi Ohta; Masataka Sugimoto; Junichi Shimada; Mitsuo Maruyama

Collaboration


Dive into the Natsuko Uekawa's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Junichi Shimada

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Kunihiko Terauchi

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Masataka Sugimoto

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Shinji Fushiki

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Takeshi Yaoi

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Kazuhiro Ito

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Masanori Shimomura

Kyoto Prefectural University of Medicine

View shared research outputs
Researchain Logo
Decentralizing Knowledge